Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | E2F7 |
| Upstream (Parents) |
|---|
| (<<) CCDC88A → E2F7 |
| (<<) CCNB1 → E2F7 |
| (<<) CCNB2 → E2F7 |
| (<<) CENPF → E2F7 |
| (<<) CHAF1A → E2F7 |
| (<<) CYB561D1 → E2F7 |
| (<<) DUSP6 → E2F7 |
| (<<) E2F1 → E2F7 |
| (<<) E2F2 → E2F7 |
| (<<) E2F3 → E2F7 |
| (<<) ELF1 → E2F7 |
| (<<) FZD4 → E2F7 |
| (<<) LIG1 → E2F7 |
| (<<) MLPH → E2F7 |
| (<<) MYLK → E2F7 |
| (<<) OAF → E2F7 |
| (<<) PLK1 → E2F7 |
| (<<) PRKCH → E2F7 |
| (<<) PRKX → E2F7 |
| (<<) RB1 → E2F7 |
| (<<) SPAG5 → E2F7 |
| (<<) SPDEF → E2F7 |
| (<<) TPM3 → E2F7 |
| (<<) UBE2C → E2F7 |
| (<<) ZNF467 → E2F7 |
| Downstream (Children) |
|---|
| E2F7 → CHPF (>>) |
| E2F7 → CTPS (>>) |
| E2F7 → DYRK1A (>>) |
| E2F7 → FZD6 (>>) |
| E2F7 → GNG4 (>>) |
| E2F7 → GSTK1 (>>) |
| E2F7 → GULP1 (>>) |
| E2F7 → INF2 (>>) |
| E2F7 → KLF11 (>>) |
| E2F7 → KLHL7 (>>) |
| E2F7 → MREG (>>) |
| E2F7 → MYL7 (>>) |
| E2F7 → NFIB (>>) |
| E2F7 → NMU (>>) |
| E2F7 → NOTCH1 (>>) |
| E2F7 → PHGDH (>>) |
| E2F7 → PIK3C3 (>>) |
| E2F7 → PTPLA (>>) |
| E2F7 → RAD51L3 (>>) |
| E2F7 → RNF138 (>>) |
| E2F7 → SESN1 (>>) |
| E2F7 → SIGLEC15 (>>) |
| E2F7 → SLC25A32 (>>) |
| E2F7 → SMURF2 (>>) |
| E2F7 → ZNF224 (>>) |
